{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:32:27Z","timestamp":1792099947315,"version":"4.4.0"},"reference-count":140,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Over 5000 patients are newly diagnosed with Alopecia areata (AA) in Australia each year. AA severity varies from a single small patch to complete loss of scalp hair, body hair including eyelashes and eyebrows. Approximately 40% of affected individuals experience only a single patch and achieve spontaneous, complete and durable remission within 6\u2009months (acute AA). A further 27% develop additional patches but still attain complete remission within 12\u2009months (chronic AA). Chronic persistent AA (CPAA) is defined by an episode duration of &gt;\u200912\u2009months and occurs in approximately 33% of patients. Without systemic treatment, 55% of individuals with CPAA will have persistent multifocal relapsing and remitting disease, 30% will progress to alopecia totalis (AT) and 15% will ultimately develop alopecia universalis (AU). The physical disfigurement, unpredictable course, social isolation and rejection contribute to the psychological distress attributable to AA. A wide range of topical, intralesional and systemic agents used to treat AA were evaluated in the 2018 Australian expert consensus statement. In 2020, the international Alopecia Areata Consensus of Experts (ACE) publication stated that if reimbursed, Janus Kinase inhibitors (JAKi's) would be an ideal systemic treatment for adults with AA. TGA approval of baricitinib in 2023 and ritlecitinib in 2024 for severe AA is the first step on the pathway for these systemic medications to be reimbursed on the Australian Government Pharmaceutical Benefits Scheme (PBS). Reimbursement would significantly transform the Australian therapeutic landscape for AA. The purpose of this 2025 Update on the Australian Expert Consensus Statement on the treatment of chronic, moderate to severe AA is to augment the 2018 treatment algorithm to include these TGA\u2010approved medications and to address indications for initiation, continuation and dose titration of systemic JAKi treatment, appropriate choice of agent, satisfactory outcome measures and to provide guidance on when to discontinue successful or unsuccessful treatment.<\/jats:p>","DOI":"10.1111\/ajd.14597","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T07:59:31Z","timestamp":1759219171000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement"],"prefix":"10.1111","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0501-5311","authenticated-orcid":false,"given":"Daniella","family":"Kushnir\u2010Grinbaum","sequence":"first","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"},{"name":"Department of Dermatology Emek Medical Centre, Afula, Israel, affiliated with the Ruth and Bruce Rappaport Faculty of Medicine of the Technion Institute of Technology  Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laita","family":"Bokhari","sequence":"additional","affiliation":[{"name":"Sinclair DIRECT Dermatology Investigational Research, Education and Clinical Trials Centre  Melbourne Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Frewen","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5318-6553","authenticated-orcid":false,"given":"Anthony","family":"Moussa","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7388-1249","authenticated-orcid":false,"given":"Daranporn","family":"Triwongwaranat","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"},{"name":"Department of Dermatology, Siriraj Hospital Mahidol University  Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragini","family":"Ghiya","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0821-3656","authenticated-orcid":false,"given":"Flavia Rodrigues","family":"Dias","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5031-3492","authenticated-orcid":false,"given":"Shin Shen","family":"Yong","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1123-6882","authenticated-orcid":false,"given":"Bevin","family":"Bhoyrul","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2041-5904","authenticated-orcid":false,"given":"Zeyad","family":"Dabbagh","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4520-9815","authenticated-orcid":false,"given":"Ahmed","family":"Kazmi","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"},{"name":"Fairfield Dermatology Clinic  Melbourne Victoria Australia"},{"name":"University of Western Australia  Perth Western Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Daunton","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"},{"name":"Clinical &amp; Experimental Dermatology  Oxford United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7150-4052","authenticated-orcid":false,"given":"Jane","family":"Li","sequence":"additional","affiliation":[{"name":"Skin Health Institute  Melbourne Victoria Australia"},{"name":"Department of Medicine (Dermatology) St Vincent's Hospital Melbourne, The University of Melbourne  Melbourne Victoria Australia"},{"name":"Department of Dermatology Eastern Health  Melbourne Victoria Australia"},{"name":"Box Hill Dermatology  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-6610","authenticated-orcid":false,"given":"Leona","family":"Yip","sequence":"additional","affiliation":[{"name":"Skin Partners  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-9864","authenticated-orcid":false,"given":"Vivian","family":"Lai","sequence":"additional","affiliation":[{"name":"Royal Children's Hospital  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2905-4494","authenticated-orcid":false,"given":"Katherine","family":"York","sequence":"additional","affiliation":[{"name":"Sunshine Coast University Hospital  Birtinya Queensland Australia"},{"name":"Buderim Skin Centre  Sunshine Coast Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6368-5738","authenticated-orcid":false,"given":"William","family":"Cranwell","sequence":"additional","affiliation":[{"name":"Dermatology Clinics Australia  Newstead Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-4488","authenticated-orcid":false,"given":"Dmitri","family":"Wall","sequence":"additional","affiliation":[{"name":"Hair Restoration Blackrock  Dublin Ireland"},{"name":"Charles Institute of Dermatology, UCD School of Medicine University College Dublin  Dublin Ireland"},{"name":"Department of Dermatology Mater Misericordiae University Hospital  Dublin Ireland"},{"name":"National and International Skin Registry Solutions University College Dublin  Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-6403","authenticated-orcid":false,"given":"Samantha","family":"Eisman","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-1428","authenticated-orcid":false,"given":"Rodney","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology  East Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"e_1_2_15_2_1","unstructured":"\u201cBaricitinib Approved by the Theapeutic Goods Administration of Australia for the Treatment of Alopecia Areata [Internet] \u201d(2023) https:\/\/www.tga.gov.au\/resources\/prescription\u2010medicines\u2010registrations\/olumiant\u2010eli\u2010lilly\u2010australia\u2010pty\u2010ltd\u20101."},{"key":"e_1_2_15_3_1","unstructured":"\u201cRitlecinib Approved by the Theapeutic Goods Administration of Australia for the Treatment of Alopecia Areata [Internet] \u201d(2024) https:\/\/www.tga.gov.au\/resources\/auspmd\/litfulo\u2010ritlecitinib."},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00764-w"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae365"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.2734"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad253"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.2581"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15994"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.032"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14126"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20628"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00941-z"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.02.019"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.08.031"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.09.028"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14155"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/jidsymp.2013.7"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63151-3"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00394"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb02825.x"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1103442"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30997-3"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2024.2348062"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09114"},{"key":"e_1_2_15_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.06.032"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.5869"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.09.056"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12941"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000254503"},{"key":"e_1_2_15_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19768"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.053"},{"key":"e_1_2_15_33_1","unstructured":"\u201cThe Pharmaceutical Benfit Scheme\u2014Ciclosporin \u201dhttps:\/\/www.pbs.gov.au\/medicine\/item\/13911E\u20105636P\u20106354K\u20108660T."},{"key":"e_1_2_15_34_1","unstructured":"\u201cNational Health Survey 2017\u201318 Australian Department of Health \u201dhttps:\/\/www.health.vic.gov.au\/your\u2010health\u2010report\u2010of\u2010the\u2010chief\u2010health\u2010officer\u2010victoria\u20102018\/burden\u2010of\u2010disease\/overweight\u2010and."},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.25251\/skin.8.supp.394"},{"key":"e_1_2_15_36_1","unstructured":"\u201cUnited Kingdom National Institute for Health and Care Excellence NICE\u2014Ritlecitinib for Treating Severe Alopecia Areata in People 12\u2009Years and Over \u201d(2024) Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata."},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.09.064"},{"key":"e_1_2_15_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00370-2"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.09.032"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.08.042"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18883"},{"key":"e_1_2_15_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.004"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae385"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14282"},{"key":"e_1_2_15_45_1","volume-title":"NHMRC Additional Levels of Evidence and Grades for Recommendations for Developers of Guidelines","author":"National Health and Medical Research Council (NHMRC)","year":"2009"},{"key":"e_1_2_15_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01873-w"},{"key":"e_1_2_15_47_1","unstructured":"\u201cBaricitinib Product Information Approved by the Australian Public Assessment Reports \u201dhttps:\/\/www.tga.gov.au\/sites\/default\/files\/auspar\u2010baricitinib\u2010190321\u2010pi.pdf."},{"key":"e_1_2_15_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19665"},{"key":"e_1_2_15_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2444494"},{"key":"e_1_2_15_50_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.6b00677"},{"key":"e_1_2_15_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257\u2010024\u201000846\u20103"},{"key":"e_1_2_15_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00222-2"},{"key":"e_1_2_15_53_1","first-page":"1134","article-title":"Systematic Review and Indirect Treatment Comparisons of Ritlecitinib Against Baricitinib in Alopecia Areata","volume":"39","author":"Aceituno D.","year":"2024","journal-title":"Acta Dermato\u2010Venereologica"},{"key":"e_1_2_15_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.12.008"},{"key":"e_1_2_15_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.03.041"},{"key":"e_1_2_15_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10777-w"},{"key":"e_1_2_15_57_1","unstructured":"\u201cJanus Kinase (JAK) Inhibitors: New Measures to Reduce Risks of Major Cardiovascular Events Malignancy Venous Thromboembolism Serious Infections and Increased Mortality \u201dhttps:\/\/www.gov.uk\/drug\u2010safety\u2010update\/janus\u2010kinase\u2010jak\u2010inhibitors\u2010new\u2010measures\u2010to\u2010reduce\u2010risks\u2010of\u2010major\u2010cardiovascular\u2010events\u2010malignancy\u2010venous\u2010thromboembolism\u2010serious\u2010infections\u2010and\u2010increased\u2010mortality."},{"key":"e_1_2_15_58_1","unstructured":"\u201cLitfulo Australian Product Information \u201dhttps:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent=&id=CP\u20102024\u2010PI\u201002188\u20101&d=20240909172310101&d=20240910172310101."},{"key":"e_1_2_15_59_1","first-page":"2272","volume-title":"Dermatology","author":"Jackson J. M.","year":"2024"},{"key":"e_1_2_15_60_1","unstructured":"Australian Government Department of Health and Aged care \u201cAustralian Immunization Handbook \u201dhttps:\/\/immunisationhandbook.health.gov.au\/contents\/vaccination\u2010for\u2010special\u2010risk\u2010groups\/vaccination\u2010for\u2010people\u2010who\u2010are\u2010immunocompromised#inactivated\u2010vaccines\u2010that\u2010are\u2010routinely\u2010recommended\u2010in\u2010people\u2010who\u2010are\u2010immunocompromised."},{"key":"e_1_2_15_61_1","doi-asserted-by":"publisher","DOI":"10.5070\/D327955114"},{"key":"e_1_2_15_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00314-3"},{"key":"e_1_2_15_63_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086967"},{"key":"e_1_2_15_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.080"},{"key":"e_1_2_15_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13812"},{"key":"e_1_2_15_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.05.037"},{"issue":"3","key":"e_1_2_15_67_1","first-page":"284","article-title":"Efficacy and Safety of Oral Mega Pulse Methylprednisolone for Severe Therapy Resistant Alopecia Areata","volume":"33","author":"Bin Saif G. A.","year":"2012","journal-title":"Saudi Medical Journal"},{"key":"e_1_2_15_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1999.tb02049.x"},{"key":"e_1_2_15_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01727.x"},{"key":"e_1_2_15_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70009-X"},{"key":"e_1_2_15_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1886230"},{"key":"e_1_2_15_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.064"},{"key":"e_1_2_15_73_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.6687"},{"key":"e_1_2_15_74_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_481_16"},{"key":"e_1_2_15_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013719.pub2"},{"key":"e_1_2_15_76_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_57_19"},{"key":"e_1_2_15_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.04.1142"},{"key":"e_1_2_15_78_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5764"},{"key":"e_1_2_15_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12863"},{"key":"e_1_2_15_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.11.066"},{"key":"e_1_2_15_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.031"},{"key":"e_1_2_15_82_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2312"},{"key":"e_1_2_15_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.05.019"},{"key":"e_1_2_15_84_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.82123"},{"key":"e_1_2_15_85_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.500210.x"},{"key":"e_1_2_15_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15489"},{"key":"e_1_2_15_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14192"},{"key":"e_1_2_15_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.043"},{"key":"e_1_2_15_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2022.03.006"},{"key":"e_1_2_15_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.10.016"},{"key":"e_1_2_15_91_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1985.01660020049014"},{"issue":"2","key":"e_1_2_15_92_1","first-page":"155","article-title":"The Efficacy of Topical Minoxidil for Non\u2010Scarring Alopecia: A Systematic Review","volume":"18","author":"Sung C. T.","year":"2019","journal-title":"Journal of Drugs in Dermatology"},{"key":"e_1_2_15_93_1","doi-asserted-by":"publisher","DOI":"10.1159\/000371416"},{"key":"e_1_2_15_94_1","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_787_19"},{"key":"e_1_2_15_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15943"},{"key":"e_1_2_15_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15450"},{"key":"e_1_2_15_97_1","unstructured":"\u201cA Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up\u2010AA) \u201dhttps:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT06012240."},{"key":"e_1_2_15_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15657"},{"key":"e_1_2_15_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.050"},{"key":"e_1_2_15_100_1","doi-asserted-by":"publisher","DOI":"10.1159\/000494613"},{"key":"e_1_2_15_101_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89790"},{"key":"e_1_2_15_102_1","volume-title":"Late Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata","author":"Sunpharma.com","year":"2023"},{"key":"e_1_2_15_103_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000780"},{"key":"e_1_2_15_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15346"},{"key":"e_1_2_15_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16316"},{"key":"e_1_2_15_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.12.056"},{"key":"e_1_2_15_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.05.001"},{"key":"e_1_2_15_108_1","volume-title":"Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata (AA)","author":"clinicaltrials.gov","year":"2021"},{"key":"e_1_2_15_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.063"},{"key":"e_1_2_15_110_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac103"},{"key":"e_1_2_15_111_1","volume-title":"A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata","author":"clinicaltrials.gov","year":"2022"},{"key":"e_1_2_15_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15071"},{"key":"e_1_2_15_113_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000512"},{"key":"e_1_2_15_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.10.010"},{"key":"e_1_2_15_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.03.019"},{"key":"e_1_2_15_116_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17010"},{"key":"e_1_2_15_117_1","volume-title":"Study of Daxdilimab for the Treatment of Moderate\u2010to\u2010Severe Alopecia Areata","author":"clinicaltrials.gov","year":"2022"},{"key":"e_1_2_15_118_1","volume-title":"A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate\u2010Tosevere Alopecia Areata (AZURE)","author":"clinicaltrials.gov","year":"2022"},{"key":"e_1_2_15_119_1","volume-title":"Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate\u2010To\u2010Severe Alopecia Areata","author":"clinicaltrials.gov","year":"2020"},{"key":"e_1_2_15_120_1","volume-title":"Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata","author":"clinicaltrials.gov","year":"2022"},{"key":"e_1_2_15_121_1","volume-title":"Randomized, Double\u2010Blind, Placebo\u2010Controlled Phase 2a, Proof\u2010of\u2010Concept Trial of ADX\u2010914 Phase 2a Trial for the Treatment of Severe Alopecia Areata (SIGNAL\u2010AA)","author":"clinicaltrials.gov","year":"2023"},{"key":"e_1_2_15_122_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_59_19"},{"key":"e_1_2_15_123_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2020.3749"},{"key":"e_1_2_15_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.05.034"},{"key":"e_1_2_15_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-018-1876-y"},{"key":"e_1_2_15_126_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1616046"},{"key":"e_1_2_15_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2022.100156"},{"key":"e_1_2_15_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.10.058"},{"key":"e_1_2_15_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.07.018"},{"key":"e_1_2_15_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20419"},{"key":"e_1_2_15_131_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1304-5"},{"key":"e_1_2_15_132_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.4445"},{"key":"e_1_2_15_133_1","doi-asserted-by":"publisher","DOI":"10.1159\/000479722"},{"key":"e_1_2_15_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.11.028"},{"key":"e_1_2_15_135_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03543.x"},{"key":"e_1_2_15_136_1","doi-asserted-by":"publisher","DOI":"10.1177\/12034754231168839"},{"key":"e_1_2_15_137_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S89561"},{"key":"e_1_2_15_138_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.77511"},{"key":"e_1_2_15_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-003-0039-6"},{"key":"e_1_2_15_140_1","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llaf055"},{"key":"e_1_2_15_141_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.5839"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.14597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:38:13Z","timestamp":1763681893000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.14597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":140,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1111\/ajd.14597"],"URL":"https:\/\/doi.org\/10.1111\/ajd.14597","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"2025-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}